Executive Order 14336: Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve
| Signed | Aug 13, 2025 |
|---|---|
| Published in the Federal Register | Aug 19, 2025 |
| Citation | 90 FR 40223 (FR Doc. 2025-15823) |
| Official text | Federal Register ↗ · PDF ↗ |
How the order opens
Section 1 of the order, in its own words (not our summary):
“During my first term, my Administration acted to protect the health and security of the American people by restoring capacity for domestic production of essential pharmaceutical products.”
Federal Register notes
The Federal Register's own disposition notes for this order: earlier orders it revokes or amends, and related documents.
- See: EO 13944, August 6, 2020
← EO 14335: Enabling Competition in the Commercial Space Industry EO 14337: Revocation of Executive Order on Competition →
Source: Federal Register API (federalregister.gov). Updated Oct 14, 2026. All executive orders.